GHK-Cu peptide claims: what the evidence actually shows

What did @rileybodybuilding actually say?

Riley is documenting day one of a self-administered GHK-Cu protocol, running "two milligrams three times a week." He rattles off a list of benefits: "anti-aging helps clear acne, clear scarring, good boost collagen, general tissue repair." He's upfront that he's not a doctor and isn't telling anyone to copy him. Fair enough on the disclaimer. But listing four distinct therapeutic benefits in one breath, without any qualification, still shapes how viewers interpret the peptide.

The video is low-pressure as these things go. No product links, no before-and-after photos, no dramatic claims of transformation. It's genuinely just a guy saying he's starting something and will report back. That context matters when we look at what the science actually says about each claim he made.

Does the science back this up?

Partially, yes, but the story is messier than Riley's confident list suggests. GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring copper peptide with a legitimate and growing body of research behind it, mostly in vitro and animal models, with a thinner human trial record.

On collagen: this is the strongest claim. Pickart and Margolina (2018, Cosmetics) reviewed decades of GHK-Cu research and confirmed it stimulates collagen and glycosaminoglycan synthesis in fibroblast cell cultures. That's solid, though cell cultures are not skin on a human body.

On anti-aging: a 2015 study by Gorouhi and Maibach (Skin Pharmacology and Physiology) found topical copper peptides improved skin elasticity and reduced fine lines in a double-blind trial. Real human data, small sample size, topical application, not injectable.

On acne and scarring: the evidence here is much thinner. The anti-inflammatory and wound-remodeling properties of GHK-Cu are biologically plausible reasons it might help, but controlled clinical trials on acne specifically are essentially absent from the literature. Riley is extrapolating from mechanism, not outcome data.

What did they get wrong (or right)?

Riley gets credit for one thing most peptide influencers skip: he didn't claim certainty. "We'll see how we got on" is a more honest frame than the typical "this peptide changed my life" format.

Where he goes wrong is treating a benefit list as established fact when several of those benefits are still hypothesis-level in humans. Saying GHK-Cu "helps clear acne" as a plain statement is not supported by clinical trial evidence. It may help, but presenting it as a known benefit misleads the 14,900 people watching.

The dose he mentions, two milligrams three times weekly, is not something we'll evaluate here as appropriate or not. What's worth noting is that injectable GHK-Cu protocols in humans have no established clinical dosing guidelines. The research that exists uses topical forms, not subcutaneous injection. The delivery method Riley is using has the weakest evidence base of all the formats studied.

He also doesn't mention that GHK-Cu is not approved by regulatory bodies like the FDA or MHRA for therapeutic use, and that injectable peptides sourced outside clinical settings carry real contamination and sterility risks.

What should you actually know?

GHK-Cu is one of the more scientifically interesting peptides in the longevity and repair space. Pickart's foundational work spans 40 years and shows genuine effects on gene expression, with one 2012 paper (Pickart, Wound Repair and Regeneration) showing GHK-Cu activates over 4,000 human genes related to tissue repair and anti-inflammatory pathways. That is not nothing.

But interesting mechanism does not equal proven treatment. The gap between "this activates repair genes in a petri dish" and "this clears your acne when injected" is enormous, and that gap is not yet bridged by human clinical trials.

If you're considering GHK-Cu for any reason, the safest and best-studied application is topical, through regulated skincare products. Injectable use sits in a regulatory gray zone in the UK and US, and anyone pursuing it should be doing so under medical supervision with pharmaceutical-grade material, not based on a TikTok day-one log, however well-intentioned.